Sangamo BioSciences | Passifs Courants





Passifs Courants Changement Date
Alaunos Therapeutics USD 921K 153K 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 25.49B 3.7B 2025-12
Bayer EUR 28.96B 825M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.82B 1.26B 2025-06
Gilead Sciences USD 12.3B 1.11B 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
J&J USD 50.87B 3.31B 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09


Sangamo BioSciences Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.